Showing results (151-160 of 176) with videos related to
Sort By:
Pageof 18
Nature Genetics|April 17, 2007
Duplication of the MYB oncogene in T cell acute lymphoblastic leukemiaIdoya Lahortiga, Kim De Keersmaecker, Pieter Van Vlierberghe, et al.Blood|February 27, 2008
The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemiaPieter Van Vlierberghe, Martine van Grotel, Joëlle Tchinda, et al.Nature Communications|June 13, 2019
Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cellsKim R Kampen, Laura Fancello, Tiziana Girardi, et al.Blood|February 18, 2014
G-749, a novel FLT3 kinase inhibitor, can overcome drug resistance for the treatment of acute myeloid leukemiaHee Kyu Lee, Hong Woo Kim, In Yong Lee, et al.Nature Communications|November 8, 2024
PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemiaDominik Beck, Honghui Cao, Feng Tian, et al.Leukemia|June 23, 2018
The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALLKim R Kampen, Sergey O Sulima, Benno Verbelen, et al.Blood|September 30, 2008
Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cellsEllen Weisberg, Johannes Roesel, Guido Bold, et al.Haematologica|May 7, 2016
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implicationsValentina Gianfelici, Sabina Chiaretti, Sofie Demeyer, et al.Leukemia|March 10, 2019
Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALLKim R Kampen, Sergey O Sulima, Benno Verbelen, et al.Science Translational Medicine|May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemiaErnest Moles, Christopher B Howard, Pie Huda, et al.Pageof 18